Position in INKT
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$46
+$4 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 27 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INKT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Key Financial Inc holds $653,965 across 24 Biotechnology names. INKT ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
290 | $144,051 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
210 | $130,943 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
450 | $110,146 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
2,000 | $109,880 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
151 | $56,122 | |
| 6 | PGEN |
Precigen, Inc.
|
5,000 | $28,500 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,050 | $18,868 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
2,000 | $17,510 |
All Filings in INKT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46 | 4 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $42 | 4 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $44 | 4 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $56 | 4 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $29 | 4 | Shares | Sole | 2025-08-05 | |
| 2024-12-31 | $29 | 43 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $32 | 43 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $40 | 43 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $39 | 43 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $46 | 43 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $47 | 43 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $90 | 43 | Shares | Sole | 2023-07-28 | |
| No filing history on record for this holder in this stock. | ||||||